Literature DB >> 8021514

Secretory vesicles are the intracellular reservoir of complement receptor 1 in human neutrophils.

H Sengeløv1, L Kjeldsen, W Kroeze, M Berger, N Borregaard.   

Abstract

The subcellular localization of complement receptor 1 (CR1) was investigated in human neutrophils. CR1 was located exclusively in the light membrane fractions containing secretory vesicles and plasma membranes in Percoll density gradients of unperturbed neutrophils. Separation of plasma membranes from secretory vesicles by high-voltage free-flow electrophoresis of the light membranes from the Percoll gradient revealed that more than 80% of the CR1 was located intracellularly in secretory vesicles. After weak stimulation of neutrophils, the increase in CR1 surface expression closely paralleled both surface increase of known secretory vesicle membrane Ags and the release of matrix proteins from secretory vesicles. More potent stimulation of the neutrophils did not enhance CR1 surface expression further, in agreement with the lack of CR1 in granules as demonstrated on Percoll gradient. CR3 (Mac-1), which has been shown to be located both in secretory vesicles and in neutrophil granules, was up-regulated in parallel with CR1 after weak stimuli, whereas a profound increase of CR3 was observed after more potent stimuli in accordance with granule mobilization. These results identify secretory vesicles as the reservoir of CR1, which translocates to the plasma membrane after weak stimulation, and underscore the functional significance of this recently identified organelle.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8021514

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  ADP-ribosylation-factor-regulated phospholipase D activity localizes to secretory vesicles and mobilizes to the plasma membrane following N-formylmethionyl-leucyl-phenylalanine stimulation of human neutrophils.

Authors:  C P Morgan; H Sengelov; J Whatmore; N Borregaard; S Cockcroft
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

2.  Lipopolysaccharide-induced gelatinase granule mobilization primes neutrophils for activation by galectin-3 and formylmethionyl-Leu-Phe.

Authors:  J Almkvist; J Fäldt; C Dahlgren; H Leffler; A Karlsson
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

Review 3.  Regulation of vesicular trafficking and leukocyte function by Rab27 GTPases and their effectors.

Authors:  Sergio Daniel Catz
Journal:  J Leukoc Biol       Date:  2013-02-01       Impact factor: 4.962

Review 4.  How neutrophils kill microbes.

Authors:  Anthony W Segal
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 5.  Granules and secretory vesicles of the human neutrophil.

Authors:  N Borregaard; L Kjeldsen; K Lollike; H Sengeløv
Journal:  Clin Exp Immunol       Date:  1995-07       Impact factor: 4.330

6.  Dynamic reorganization of the alkaline phosphatase-containing compartment during chemotactic peptide stimulation of human neutrophils imaged by backscattered electrons.

Authors:  E Fernández-Segura; J M García; A Campos
Journal:  Histochem Cell Biol       Date:  1995-08       Impact factor: 4.304

7.  Opsonophagocytosis of Chlamydia pneumoniae by Human Monocytes and Neutrophils.

Authors:  Mads Lausen; Mathilde Selmar Pedersen; Nareen Sherzad Kader Rahman; Liv Therese Holm-Nielsen; Faduma Yahya Mohamed Farah; Gunna Christiansen; Svend Birkelund
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

8.  Escherichia coli-induced activation of neutrophil NADPH-oxidase: lipopolysaccharide and formylated peptides act synergistically to induce release of reactive oxygen metabolites.

Authors:  A Karlsson; M Markfjäll; N Strömberg; C Dahlgren
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  Inhibition of the neutrophil NADPH oxidase by adenosine is associated with increased movement of flavocytochrome b between subcellular fractions.

Authors:  Steve D Swain; Daniel W Siemsen; Laura K Nelson; Karen M Sipes; Angela J Hanson; Mark T Quinn
Journal:  Inflammation       Date:  2003-02       Impact factor: 4.092

10.  Serum protects against azurophil granule dependent down-regulation of complement receptor type 1 (CR1) on human neutrophils.

Authors:  J Lundahl; C Dahlgren; K Gustavsson; J Hed
Journal:  Inflamm Res       Date:  1995-10       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.